Published in AIDS Weekly, May 27th, 2002
Patients whose viral counts have fallen to nearly imperceptible levels sometimes interrupt antiviral therapy temporarily, restarting treatment if viral levels rebound. Called structured therapy interruption, these drug breaks can increase the number of certain HIV-fighting T cells, called CD8 T-cells, in the blood. Another type of T cell, CD4, also plays an important role in fighting HIV.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.